NewsBenzingaOppenheimer首次对Teva制药公司进行覆盖，给予超越市场表现的评级，宣布目标股价为50美元 Oppenheimer首次对Teva制药公司进行覆盖，给予超越市场表现的评级，宣布目标股价为50美元 Benzinga 2026.09.23 12:08 (GMT+0) Open on Benzinga Other news Puma Biotechnology Reports Q2 2026 Results: Full Earnings Call Transcript Transcript: Rocket Companies Q2 2026 Earnings Conference Call Reported Earlier, China Passenger Car Sales Fall 28.1% YoY To 1.63M In September, Tesla Exported 30,529 China-Made Vehicles, Per CPCA SWI Group completes €800 million financing to accelerate conversion of Bitcoin mining sites into AI computing infrastructure Stephen King Slams Trump’s New Press Secretary as Past Vaccine Conspiracy Theories, Third-Term Posts Spark Fresh Controversy: 'She Appears to Have Tried to…' Full Transcript: MDU Resources Gr Q2 2026 Earnings Call
Reported Earlier, China Passenger Car Sales Fall 28.1% YoY To 1.63M In September, Tesla Exported 30,529 China-Made Vehicles, Per CPCA
SWI Group completes €800 million financing to accelerate conversion of Bitcoin mining sites into AI computing infrastructure
Stephen King Slams Trump’s New Press Secretary as Past Vaccine Conspiracy Theories, Third-Term Posts Spark Fresh Controversy: 'She Appears to Have Tried to…'
